« Previous
Next »
Journal of Cardiac Failure
Volume 16, Issue 1
, Pages 84-90
, January 2010
Abnormal Liver Function in Relation to Hemodynamic Profile in Heart Failure Patients
References
- ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail. 2008;10:933–989
- Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH). Arch Intern Med. 2008;168:316–324
- Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol. 2008;52:818–827
- Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation. 2006;113:671–678
- . The prognostic influence of chronic obstructive pulmonary disease in patients hospitalised for chronic heart failure. Eur J Heart Fail. 2007;9:942–948
- Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail. 2007;9:872–878
- . Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol. 2009;53:582–588
- Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail. 2009;11:170–177
- . The importance of abnormalities of liver function tests in predicting mortality in chronic heart failure. Eur Heart J. 1995;16:1613–1618
- . Liver function tests in chronic congestive heart failure. Circulation. 1950;2:286–297
- . Liver function in congestive heart failure. J Clin Invest. 1930;8:419–433
- . An estimation of the hepatic blood flow and splanchnic oxygen consumption in heart failure. J Clin Invest. 1948;27:620–627
- . Alterations in indices of liver function in congestive heart failure with particular reference to serum enzymes. Am J Med. 1961;30:211–225
- . The liver in heart failure; relation of anatomical, functional, and circulatory changes. Br Heart J. 1951;13:273–293
- Prognostic significance of increased serum bilirubin levels coincident with cardiac decompensation in chronic heart failure. Circ J. 2008;72:364–369
- . Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. Medicine (Baltimore). 2003;82:392–406
- . Liver function abnormalities in chronic heart failure. Influence of systemic hemodynamics. Arch Intern Med. 1987;147:1227–1230
- . Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation. Am J Cardiol. 2002;90:1405–1409
- . Review article: drug hepatotoxicity. Aliment Pharmacol Ther. 2007;25:1135–1151
- . The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA. 1989;261:884–888
- . Heart diseases affecting the liver and liver diseases affecting the heart. Am Heart J. 2000;140:111–120
- . The liver in congestive heart failure. Am Heart J. 1955;49:250–257
The authors have no conflicts of interest.
K. Damman is supported by the Netherlands Heart Foundation (grant 2006B157). A.A. Voors and D.J. van Veldhuisen are Clinical Established Investigators of the Netherlands Heart Foundation (grants 2006T37 and D97-017, respectively).
PII: S1071-9164(09)00957-9
doi: 10.1016/j.cardfail.2009.08.002
© 2010 Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Cardiac Failure
Volume 16, Issue 1
, Pages 84-90
, January 2010
